Veriheal
FEBRUARY 19, 2021
The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. .
Cannabis Chronicles
MAY 22, 2019
SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. The Puyallup tribe has staked several claims in the state’s legal marijuana industry, opening two recreational stores in the Tacoma area.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
FEBRUARY 14, 2024
In a recent hearing, the Arizona Senate Health and Human Services Committee unanimously approved a bill that would legalize therapeutic psilocybin centers for medically supervised use. This will also include licensing for centers that are working on psilocybin and psychedelic research.
Veriheal
FEBRUARY 28, 2022
Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A press release announcing the scientists’ research explains that the team has “designed two new compounds that can relieve depression but do not cause the unwanted effect of hallucination.” A New Kind of Depression Treatment.
The Cannigma
JULY 1, 2022
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.
Veriheal
APRIL 11, 2022
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.
Expert insights. Personalized for you.
87 
Let's personalize your content